Incannex (IXHL) Healthcare announced positive topline results from a completed pharmacokinetics, PK, and safety study of IHL-42X, a novel, oral fixed-dose combination of acetazolamide and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback